Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages

T C Edwards1, J Emerson2, A Genatossio2

  • 1Department of Health Services, University of Washington, 1208 NE 43rd St. - Campus Box 359455, Seattle, WA 98195-9455, United States.

Insights

Observer-reported outcomes (ObsROs) are promising for young children with cystic fibrosis (CF). Parent-reported instruments showed good reliability for ages 0-6, suggesting potential for early intervention trials in pediatric CF patients.

Area of Science:

  • Pediatric clinical trial methodology
  • Respiratory medicine
  • Patient-reported outcomes research

Background:

  • Patient-reported outcomes (PROs) are crucial clinical trial endpoints.
  • Young children often cannot reliably self-report, necessitating observer-reported outcomes (ObsROs).
  • Cystic Fibrosis (CF) requires reliable outcome measures in pediatric populations.

Purpose of the Study:

  • To develop and pilot electronic parent-reported observational instruments for children with CF aged 0-6 and 7-11 years.
  • To assess the feasibility and preliminary psychometric properties of these instruments.
  • To inform the development of appropriate endpoints for early intervention trials in young children with CF.

Main Methods:

  • Concept elicitation interviews with parents of children with CF (≤11 years) to identify observable signs.
  • Instrument refinement based on parent and clinician feedback.
  • Pilot field testing to evaluate test-retest reliability and discriminative ability between well and sick states.

Main Results:

  • Developed a 17-item observational instrument assessing respiratory signs and CF impacts.
  • Achieved acceptable test-retest reliability for both age groups (0-6 and 7-11 years).
  • Observed low discriminative ability for the 7-11 year age group, potentially due to decreased parental observation.

Conclusions:

  • Parent-reported ObsROs show promise for children with CF aged 0-6 years.
  • Self-report may be more suitable for children with CF older than 6 years.
  • The 0-6 year instrument is a potential endpoint for early intervention clinical trials in pediatric CF, requiring further validation.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
549
Self-Report Tests of Personality01:22

Self-Report Tests of Personality

Self-report inventories are objective personality assessments that use multiple-choice items or numbered scales, typically ranging from 1 (strongly disagree) to 5 (strongly agree). They are often called Likert scales after Rensis Likert. These inventories are widely used due to their ease of administration and cost-effectiveness. One of the most prominent examples is the Minnesota Multiphasic Personality Inventory (MMPI), initially developed in the 1940s to assess abnormal personality traits.
888
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
Initiation of Translation02:33

Initiation of Translation

8.2K
Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
496